Now available in the United States, Australia, New Zealand and Canada

Illuccix® (kit for the preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as 68Ga-PSMA-11 injection) has been approved by the Australian Therapeutic Goods Administration (TGA), the United States Food and Drug Administration (FDA), and Health Canada.

Registrations vary country to country, always check the approved local product label. Full Product information available.

Illuccix® may be available to patients outside of approved jurisdictions per Telix’s compassionate use policy.